PHARMACOECONOMIC ANALYSIS OF USE OF PENTAVALENT COMBINATION VACCINE WITH ACELLULAR PERTUSSIS COMPONENT IN THE FRAMEWORK OF THE REGIONAL IMMUNIZATION SCHEDULE OF KRASNODAR FOR ALL CHILDREN AGED 0–18 MONTHS AND SEPARATLY FOR CHILDREN AT RISK
https://doi.org/10.15690/pf.v11i6.1213
Abstract
Introduction. On the one hand, extension of the immunization schedule provides protection from more infections; on the other hand, it increases the injection load, especially in young children. That is why inclusion of combination vaccines, which could help to reduce the amount of injections, is relevant. The study was aimed at conducting pharmacoeconomic evaluation of including combination pentavalent acellular vaccine against diphtheria, pertussis, tetanus, poliomyelitis, Haemophilus influenzae type b (DTaP-IPV/Hib) to the regional immunization schedule of Krasnodar for all children and separately for children at risk. Methods. Modeling; economic methods of estimation: cost-effectiveness analysis, cost-utility analysis, budget impact analysis. Results. Analysis yielded the following data: in terms of the healthcare system, 4 pentavalent vaccine injections will require additional costs of 1,316,533 rubles per unit of effectiveness and 1,298,846 rubles per unit of utility. In terms of the region and society, transition from the current scenario to a combination vaccine scenario will help to save 9,778,821 rubles in the entire cohort over the entire horizon period. In terms of the healthcare system, according to the budget impact analysis, transition from the current scenario to a DTaP scenario will require additional investments of 16,349,631 rubles, transition to a pentavalent vaccine scenario — 7,208,861 rubles; in terms of the region and society — 16,191,343 rubles and 7,050,573 rubles, respectively. Conclusions. In terms of the incremental cost-effectiveness and cost-utility analyses, scenario 1 (4 combination pentavalent vaccine injections) is strongly preferred (dominant) from the regional perspective and acceptable from the healthcare system’s perspective. According to the budget impact analysis and taking into account only the healthcare system’s costs, transition from the current immunization schedule to a combination vaccine schedule will require
additional investments. However, it will help to reduce regional expenses, given the social and other expenses not covered by the healthcare system’s budget. In the event of vaccination of children at risk and comparison of reasonability of transition from the current immunization schedule to an acellular DTP (DTaP) schedule or a pentavalent combination vaccine schedule, the budget impact analysis demonstrated that transition from the current immunization schedule for children at risk to a pentavalent vaccine schedule is dominant
in comparison with the perspective of transition to a schedule consisting in 4 DTaP injections.
additional investments. However, it will help to reduce regional expenses, given the social and other expenses not covered by the healthcare system’s budget. In the event of vaccination of children at risk and comparison of reasonability of transition from the current immunization schedule to an acellular DTP (DTaP) schedule or a pentavalent combination vaccine schedule, the budget impact analysis demonstrated that transition from the current immunization schedule for children at risk to a pentavalent vaccine schedule is dominant
in comparison with the perspective of transition to a schedule consisting in 4 DTaP injections.
About the Authors
A. Yu. Kulikov
National Research Intstitut of Public Health, Moscow, Russian Federation
Russian Federation
Russian Federation
Yu. I. Akimova
Sechenov First Moscow State Medical University, Moscow, Russian Federation
Russian Federation
Russian Federation
References
1. Prikaz Ministerstva zdravookhraneniya RF ot 21 marta 2014 g. № 125n «Ob utverzhdenii natsional'nogo kalendarya profilakticheskikh privivok i kalendarya profilakticheskikh privivok po epidemicheskim pokazaniyam». Dostup iz spravochnopravovoi sistemy «Konsul'tantPlyus» [Order of the Ministry of Health on March 21, 2014 № 125n "On approval of the National Immunization Schedule and Calendar preventive vaccination on epidemic indications." Access from reference-law system "Consultant"].
2. Ishmukhametov A. A., D'yakov I. N. National Immunization Schedule. Current realities and prospects. Remedium = Remedium. 2013; 12: 3–10.
3. Epidemiologiya i vaktsinoprofilaktika infektsii, vyzyvaemoi Haemophilus influenzae tipa b. Metodicheskie rekomendatsii [Epidemiology and vaccination infection caused by Haemophilus influenzae type b. Methodical recommendations]. Moscow, Federal'naya sluzhba po nadzoru v sfere zashchity prav potrebitelei i blagopoluchiya cheloveka, 2010. 41 p.
4. Prilozhenie № 1 k protokolu kollegii Federal'noi sluzhby po nadzoru v sfere zashchity prav potrebitelei i blagopoluchiya cheloveka ot 26.06.2014 № 5. Reshenie kollegii Federal'noi sluzhby po nadzoru v sfere zashchity prav potrebitelei i blagopoluchiya cheloveka. Aktual'nye voprosy epidemiologicheskogo nadzora i profilaktiki bakterial'nykh meningitov v Rossiiskoi Federatsii (Appendix 1 to the protocol number board of the Federal Service for Supervision of Consumer Rights Protection and Human Welfare of 26.06.2014 № 5. Bench decision of the Federal Service for Supervision of Consumer Rights Protection and Human Welfare. Topical issues of surveillance and prevention of bacterial meningitis in the Russian Federation). Available at: http://rospotrebnadzor.ru/upload/iblock/71d/reshenie-kollegii-5.pdf
5. Fedorov A. M., Lyashko V. V. Vsya pravda o privivkakh [The Whole Truth about Vaccinations]. Moscow, Metafora, 2012. 429 p.
6. Livartowski A., Boucher J., Detournay B., Reinert P. Cost-effectiveness evaluation of vaccination against Haemophilus influenzae invasive diseases in France. Vaccine. 1996; 14: 495–500.
7. Tatochenko V.K., Katosova L.K., Fedorov A.M. Haemophilus influenzae type b and prospects struggle in Russia.. Detskie infektsii = Child infections. 2003; 4: 51–53.
8. Edmond K., Clark A., Korczak V. S., Sanderson C., Griffiths U. K., Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2010; 10: 317–328.
9. Tatochenko V. K., Namazova L. S., Kharit S. M. Reactogenicity and safety of vaccines adsorbed pertussis, diphtheria and tetanus: results of observational studies. Voprosy sovremennoi pediatrii = Current Pediatrics. 2006; 5 (4): 32–38.
10. Kharit S. M., Chernyaeva T. V., Nacharova E. P., Vasil'eva G. A., Ruleva A. A. Safety Assessment revaccination of children overn1.5 years against diphtheria, pertussis, tetanus, polio and Haemophilus influenzae type b vaccine Pentaxim. Zhurnal infektologii = Journal of infectology. 2009; 1 (2/3): 73–78.
11. Volyanskii A. Yu., Yarmysh A. D., Yamchitskaya A. A. Opyt primeneniya kombinirovannykh vaktsin, soderzhashchikh atsellyulyarnyi koklyushnyi komponent. Vaktsinatsiya. Novosti vaktsinoprofilaktiki (Experience of combination vaccines containing acellular pertussis component. Vaccination. News of vaccination). Available at: http://medi.ru/doc/15b3505.html
12. O sluchayakh vaktsinoassotsiirovannogo paraliticheskogo poliomielita v Rossiiskoi Federatsii (The cases of vaccine-associated paralytic poliomyelitis in the Russian Federation). Available at: http://www.09.rospotrebnadzor.ru/news/-/asset_publisher/h4Wo/content/ Accessed 2014-0
13. Federal'naya sluzhba gosudarstvennoi statistiki (Federal State Statistics Service). Available at: http://www.gks.ru
14. Yagudina R. I., Kulikov A. Yu., Komarov I. A. Methodology of cost analysis during the pharmacoeconomic studies. Farmakoekonomika = Pharmacoeconomics. 2011; 3: 3–6.
15. Gidengil C., Lieu T. A., Payne K., Rusinak D., Messonnier M., Prosser L. A. Parental and societal values for the risks and benefits of childhood combination vaccines. Vaccine. 2012; 30 (45): 3445–3452.
16. Gosudarstvennyi doklad «O sostoyanii sanitarno-epidemiologicheskogo blagopoluchiya naseleniya v Rossiiskoi Federatsii v 2012 godu» (State report "On the state sanitary and epidemiological welfare of the population in the Russian Federation in 2012"). Available at: http://rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=1178
17. Prikaz ot 24 dekabrya 2012 g. № 806n «Ob utverzhdenii standarta spetsializirovannoi meditsinskoi pomoshchi detyam pri koklyushe srednei stepeni tyazhesti». Zaregistrirovano v Minyuste Rossii 29 yanvarya 2012 g. № 26888 [Order № 806n "On approval of the standard of specialized care for children with whooping cough moderate severity" dated December 24, 2012. Registered as № 26888 with the Russian Ministry of Justice dated January 29, 2012].
18. Immunization essentials: a practical field guide [Chapter 10. Costs and financing]. USAID. 2003. Available at: http://pdf.usaid.gov/pdf_docs/PNACU960.pdf
19. Tarify na meditsinskie uslugi MGFOMS (Fees for medical services MGFOMS). Available at: http://www.mgfoms.ru/?page_id=5198
20. Prikaz ot 24 dekabrya 2012 g. № 1536n «Ob utverzhdenii standarta spetsializirovannoi meditsinskoi pomoshchi detyam pri seroznom meningite srednei stepeni tyazhesti». Zaregistrirovano v Minyuste Rossii 22 marta 2013 g. № 26664 [Order number 1536n "On approval of the standard of specialized care for children with serous meningitis moderate severity" dated December 24, 2012. Registered as № 26664 with the Russian Ministry of Justice March 22, 2013].
21. Baranov A. A. Klinicheskie rekomendatsii po diagnostike i lecheniyu ostrykh respiratornykh zabolevanii (ORZ), lecheniyu pnevmonii u detei (Clinical Recommendations for diagnosis and treatment of acute respiratory infections (ARI), the treatment of pneumonia in children). 2014. Available at: http://www/posminzdrav.ru/documents
22. Postanovlenie Pravitel'stva RF ot 28.12.2012 № 661-PP «O programme gosudarstvennykh garantii okazaniya grazhdanam Rossiiskoi Federatsii besplatnoi meditsinskoi pomoshchi na 2013 god i na planovyi period 2014 i 2015 godov» (Government Decree № 661-PP "On the program of state guarantees of citizens of the Russian Federation with free medical care in 2013 and the planned period 2014 and 2015" dated 28.12.2012). Available at: http://www.rosminzdrav.ru/documents/6823proekt-postanovleniya-pravitelstva-rf-ot-25-iyulya-2012-g
23. Prais-list klinik Pervogo MGMU im. I. M. Sechenova (Prices of the clinics at I.M. Sechenov First MSMU). Available at: http://www.mma.ru
24. Reestr zaregistrirovannykh tsen na ZhNVLP (Register for the VED price). Available at: http://www.minzravsoc.ru/medicine
25. Poisk lekarstv v aptekakh Rossii (Search of medicines in pharmacies Russia). Available at: http://www.aptechka.ru
26. Prikaz Ministerstva zdravookhraneniya i sotsial'nogo razvitiya Rossiiskoi Federatsii ot 28.02.2005 № 174. Standart meditsinskoi pomoshchi bol'nym epilepsiei (Order of the Ministry of Health and Social Development of the Russian Federation № 174. The standard of care in patients with epilepsy dated 02.28.2005). Available at: http://www.consultant.ru
27. Federal'nyi perechen' reabilitatsionnykh meropriyatii, tekhnicheskikh sredstv reabilitatsii i uslug predostavlyaemy invalidu Utverzhden rasporyazheniem Pravitel'stva Rossiiskoi Federatsii ot 30 dekabrya 2005 g. № 2347-r (Federal list of rehabilitation activities, facilities and rehabilitation services affordances invalid approved by the Federal Government № 2347-p dated December 30, 2005). Available at: http://www.voginfo.ru/main/legal_support/317
28. Kulikov A. Yu., Akimova Yu. I. Methodology pharmacoeconomic analysis of vaccine prevention. Farmakoekonomika = Pharmacoeconomics. 2013; 1: 4–10.
29. Yagudina R. I.,Kulikov A. Yu., Litvinenko M.M. QALY: history, methodology and future of the approach. Farmakoekonomika = Pharmacoeconomics. 2010; 1: 7–11.
Review
For citations:
Kulikov A.Yu., Akimova Yu.I. PHARMACOECONOMIC ANALYSIS OF USE OF PENTAVALENT COMBINATION VACCINE WITH ACELLULAR PERTUSSIS COMPONENT IN THE FRAMEWORK OF THE REGIONAL IMMUNIZATION SCHEDULE OF KRASNODAR FOR ALL CHILDREN AGED 0–18 MONTHS AND SEPARATLY FOR CHILDREN AT RISK. Pediatric pharmacology. 2014;11(6):30-41. (In Russ.) https://doi.org/10.15690/pf.v11i6.1213
Views:
1340
Email this article 